PsychRounds: The Psychiatry Podcast

Pharmacogenetic Testing in Psychiatry

Welcome back, everyone! We’re back after PRITE, and today we’re discussing pharmacogenetic testing.

GLP-1 Agonists (Ozempic, Wegovy) in Psychiatry

Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry. Sources: https://pubmed.ncbi.nlm.nih.gov/42247271/ https://pmc.ncbi.nlm

Landmark Studies: The STAR*D Trial

We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression)

Dogs in Mental Health with Dr. Nancy Gee: A Biopsychosocial Approach

We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental heal

Centanafadine (Simtriyo): A New Medication for ADHD

Welcome back! Today, we are talking about Simtriyo, which has generated a lot of media attention recently given a newly minted FDA approval for ADHD. References  https:

Landmark Studies: The CATIE Trial

Today we're starting a new type of series - looking at some of the most seminal studies in psychiatry. We're going to start with the CATIE Trial, which was published in 2

The Rising Use of Recreational Kratom

Apologies for our little hiatus - a couple of us had cross-country moves in June. But we're back! Today we have an episode on the rising use of recreational Kratom and pe

Modafinil (Provigil)

Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry. References: Provigil (modafinil) [prescribing information]. North Wales, PA: Teva P

Naltrexone

Welcome Back! Today we are discussing the medication Naltrexone and its uses in psychiatry. References: https://www.ncbi.nlm.nih.gov/books/NBK534811/ https://pubmed.

Placebo Effect and Response in Psychiatry

Welcome back! Today, we will be discussing the placebo effect. References: https://pubmed.ncbi.nlm.nih.gov/16503356/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC60036

Amantadine (Symmetrel)

Welcome back! Today we are talking all about Amantadine, and it's uses in psychiatry.

VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)

Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).

A DSM Conversation with Dr. Allen Frances

We are back with another special guest episode! Please welcome Dr. Allen Frances, who was intricately involved in the formation of both the DSM III and DSM IV, the latter

Topiramate (Topamax)

Welcome back! Today we will be doing a brief episode on Topiramate [Topamax], and its clinical uses in psychiatry. References: https://pubmed.ncbi.nlm.nih.gov/21438989/

What Makes Something a Psychiatric Illness? Featuring Dr. Mark Ruffalo, MSW, DPsa

Welcome back, today we are discussing a deceptively difficult topic: What makes something a psychiatric illness? We are joined by our guest Dr. Mark Ruffalo. He is a psyc

Lorazepam (Ativan)

Welcome back! Today we are at the highly prescribed and popular benzodiazepine Lorazepam, also known as Ativan. We look at its uses in psychiatry, especially catatonia. B

The Vitamin Series: Iron Deficiency in Psychiatry

Welcome back! Today we are embarking into the first of hopefully several episodes on the importance of vitamins and minerals in mental health. We will specifically be loo

Nutritional Psychiatry with Dr. Laura Lachance

Welcome back! Today our topic is Nutritional Psychiatry and we've invited a special guest - Dr. Laura Lachance, who has done extensive research in the field. Along with D

Stress, Culture, and Determinism with Dr. Robert Sapolsky

Welcome back! Today, we are hosting the highly accomplished Dr. Robert Sapolsky, PHD, a professor of professor of biology, neurology, and neurosurgery at Stanford Univers

SSRIs Revisited: The 100th Episode

One hundred episodes later, let’s take it back to one of our very first, the Selective Serotonin Reuptake Inhibitors - with a much-needed update. Thank you to our guests,